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Socioeconomic impacts of nosocomial infection
(NI), including prolongation of hospital stay, 
increment of medical costs and deaths, are well
recognized. However, most studies focusing on
fatality among patients with NI have been dis-
crete and specific in nature (e.g. elderly patients;1
stroke victims;2 patients in intensive care units
[ICUs];3,4 specific body sites including blood,5 res-
piratory tract6 or surgical wound;7 and infections
with multidrug resistant microorganisms includ-
ing methicillin-resistant Staphylococcus aureus,8
extended-spectrum β-lactamase producing Entero-
bacteriaceae,9 and Pseudomonas aeruginosa).10 Stud-
ies discussing risk factors of mortality attributable to
overall NI are few.11,12
With the introduction of advanced diagnostic
and therapeutic approach to immunocompro-
mised patients over the recent decades, the risk
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Background/Purpose: Nosocomial infection (NI)-associated death is an important issue for both patients
and clinicians, and is of emerging importance in public health. This study investigated the factors associated
with in-hospital deaths among patients with NI.
Methods: Between July 1, 2002 and June 30, 2003, a total of 1574 patients with NI at National Taiwan
University Hospital were enrolled to investigate the factors associated with fatal outcome. Host factors, hos-
pital services, surgical and medical interventions, microbial factors, infection sites, and the treatment and
complications of NI were analyzed retrospectively.
Results: During the study period, 554 of the 1574 patients died (mortality rate, 28.3%). NI was directly
involved in 80.5% of them (n = 446), and over two-thirds (67.9%) of deaths occurred within 2 weeks of
NI onset. Sixteen variables were statistically implicated as independent factors significantly associated
with mortality. Host factors included higher disease severity (p < 0.0001), liver cirrhosis (p < 0.0001), solid
tumors (p < 0.0001), chronic lung disease (p = 0.003), and congestive heart failure (p = 0.005). Hospital and
interventional factors included intensive care hospitalization (p = 0.002), longer hospitalization before NI
onset (p = 0.004), hemodialysis (p = 0.0003), arterial-line insertion (p < 0.0001), urinary catheterization
(p < 0.0001), and central venous catheterization (p = 0.001). Blood stream infections (p < 0.0001), NI due to
Candida (p < 0.0001), and multiple (≥ 2) episodes of NI (p < 0.0001) were significant risk factors for death,
as were occurrence of NI-associated septic shock (p < 0.0001) and disseminated intravascular coagulation
(p < 0.0001). No significant associations of mortality with age, sex, species of bacteria, multi-antibiotic 
resistant bacteria, regimen for initial treatment, or multiple antibiotic therapy were evident.
Conclusion: Measures that prevent the occurrence of NI, such as improving the immunity status of the host,
removal of catheters as soon as possible, and implementing an infection control program, could reduce the
risk of in-hospital deaths attributable to NI. [J Formos Med Assoc 2007;106(2):110–118]
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factors of mortality associated with NI may be
different from those determined in previous
studies.11,12 Underlying diseases, impaired host
defense, use of invasive devices, immunosuppres-
sive therapy or antimicrobials, and colonization
with resistant microorganisms can make hospital-
ized patients highly susceptible to NI.3,4 However,
whether or not these risk factors for NI are signifi-
cant mortality factors is unclear.
Early detection of patients with higher risk for
in-hospital deaths would be useful for clinical care
and is very important in an environment where
clinicians and nurses are burdened with patient care
responsibilities and where resources for infection
control may be limited. The present study aimed to
investigate the factors associated with in-hospital
deaths among patients with NI. Host factors, hos-
pital services, surgical and medical interventions,
microbial factors, infection sites, and the treat-
ment and complications of NI were analyzed.
Methods
Setting
The study was performed at National Taiwan
University Hospital (NTUH), a 2200-bed medical
center located in northern Taiwan that provides
both primary and tertiary referral care. Annually,
60,000–70,000 patients are discharged. Hospital-
wide active surveillance of NI has been conducted
by infection control nurses since 1980 to identify
all hospitalized patients with NI. From 1992–
2004, the average NI rate was 4.6 infections per
100 discharges (range, 3.9–6.6).
Study design
All hospitalized patients with NI between July 1,
2002 and June 30, 2003 were recruited. To study
the event of death and prevent confounding,
only the last NI episode was analyzed for those
patients who experienced multiple hospitalizations
and/or episodes of NI. All patients were followed
until death or discharge. To clarify NI-associated
mortality contributors, patients who died from
NI were assigned as cases and those who survived
constituted the controls. Test variables included
host factors (age, sex, underlying systemic illnesses,
disease severity); hospital environment factors
(admission ward, hospitalized days, invasive pro-
cedures performed before development of NI); sites
of NI in the patient; microbial factors (causative
pathogen, pathogen antimicrobial susceptibilities,
use/complications of antimicrobial agents). A stan-
dardized case record form was used to retrieve
clinical and demographic data of case patients and
controls, diagnostic and therapeutic interventions,
complications of NI, and final outcomes.
Definitions
Deaths were considered to be associated with NI if
the NI was still active and being treated with an-
tibiotics when death occurred and no other obvi-
ous causes of death were evident. NI was diagnosed
according to the definitions of the United States
Centers for Disease Control and Prevention.13
Severity of underlying disease classification was
evaluated at the time of NI occurrence, using an
established modified risk stratification regimen,14
as rapidly fatal (death anticipated during hospi-
talization), ultimately fatal (death anticipated
within 5 years), or non-fatal (disease unlikely to
be fatal within 5 years or absence of underlying
disease). APACHE II scores were not available be-
cause not every patient underwent detailed blood
biochemistry and blood gas analyses at the time
of NI occurrence. Multiple drug resistance was
defined as resistance to three or more classes of
antimicrobial agents. Multiple antimicrobial ther-
apy was considered to be the use of three or more
classes of antimicrobial agents. Initial effective
antimicrobial treatment was defined as the con-
trol of all NI causative pathogens by the antimi-
crobials used at the time of NI occurrence.
Microbiology
Culturing of specimens was performed at the
NTUH clinical microbiology laboratory and bac-
teria were identified using conventional culture-
based methods, and the VITEK and/or API systems.
Antimicrobial susceptibility was determined
using the Kirby-Bauer disc-diffusion technique,
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as described by the US Clinical and Laboratory
Standards Institute (CLSI).15
Statistical analyses
Statistical analyses were performed using SAS
version 8.2 (SAS Institute Inc., Cary, NC, USA).
Continuous variables were compared using the
Mann–Whitney U test or Student’s t test, and cate-
gorical variables were compared using χ2 or Fisher’s
exact tests. Variables associated with deaths in
univariate analysis with p < 0.1 were entered into
multivariate analysis by using multiple logistic
regression with a stepwise forward and backward
model to determine the independent variable and
identify variables associated with death. All tests
were two-tailed and p<0.05 was considered signif-
icant. Odds ratios and 95% confidence intervals
were computed for variables independently asso-
ciated with deaths.
Results
Patients
Between July 1, 2002 and June 30, 2003, there were
2635 episodes of NI involving 1574 patients at
NTUH. Multiple episodes of NI occurred in 592
patients (37.6%). The median age of the patients
was 65 years (range, 0–93 years) and 894 (56.8%)
were male. Of the total number of patients, 554
died, with death being directly attributed to NI in
446 (80.5%). The NI-attributable mortality rates
were 7.2 per 1000 discharges, 30.1 per 100 patients
admitted to the ICU, 28.3 per 100 patients with
NI, and 16.9 per 100 episodes of NI. The majority
of NI-attributable deaths (284 patients, 63.7%)
occurred within 2 weeks of NI (Figure). The me-
dian (25th, 75th percentile) hospitalized days from
admission to development of NI and NI to deaths
were 21 (11–37) days and 8 (4–18) days.
Univariate analysis of variables 
for mortality
For host factors, nine were risk factors significantly
associated with mortality (Table 1). Patients with
rapidly fatal diseases, longer hospital stay before
NI occurred, patients with malignancies, recent
chemotherapy or radiotherapy, chronic renal dis-
eases, chronic heart diseases, chronic liver diseases,
and chronic lung diseases had higher proportion of
deaths. In contrast, patients with neurologic dis-
eases had a lower risk for death. There were no sig-
nificant differences in age, sex, recent operation and
total number of hospitalized days of the patients.
Concerning hospital factors, a significantly
higher proportion of deaths were evident in pa-
tients admitted to the ICU and oncology wards,
while mortality was lower for patients admitted to
services of general medicine, orthopedics, and reha-
bilitation. Concerning invasive medical and surgi-
cal interventions, a higher proportion of death was
found in patients who received insertions of arterial
lines, chest tubes, central venous catheters, urinary
catheters, Port-A devices, and Swan-Ganz catheters.
Likewise, increased risk of mortality was evident in
patients receiving hemodialysis, endoscopic exami-
nation, total parenteral nutrition, and immuno-
suppressive steroid or chemotherapy (Table 2).
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Concerning sites of infection and causative
pathogens of NI, patients with bloodstream in-
fections had a higher risk of death, while patients
with urinary tract infections had a lower risk of
death. Patients infected with Staphylococcus aureus
and Candida had a higher risk of death, while pa-
tients infected with Pseudomonas aeruginosa and
Escherichia coli had a lower risk (Table 3).
Concerning treatment and complications of NI,
there was no significant difference in mortality
between patients with or without initial use of
appropriate antibiotics covering all causative
pathogens at NI onset. Similarly, neither antibiotic
resistance of the pathogens nor use of multiple an-
tibiotics influenced mortality. However, a higher
proportion of deaths were evident in patients who
developed complications related to NI, including
disseminated intravascular coagulation (DIC), gas-
trointestinal bleeding, acute renal failure, cardio-
pulmonary resuscitation, septic shock and acute
respiratory distress syndrome (Table 4).
Independent predictors for mortality
By multiple logistic regression analysis, 16 vari-
ables were identified as independent risk factors:
patients with higher disease severity (rapidly fatal
diseases vs. non-fatal diseases, odds ratio [OR], 8.21;
p < 0.0001), liver cirrhosis (OR, 5.58; p < 0.0001),
solid malignant tumors (OR, 2.56; p < 0.0001),
chronic lung diseases (OR, 1.99; p = 0.003), and
congestive heart failure (OR, 1.75; p = 0.005),
more extended ICU hospitalization (OR, 1.61;
Table 1. Demographic and clinical characteristics of 1574 patients with nosocomial infections (host factors)*
Host characteristics† Survived (n = 1128) Died (n = 446) p
Age (yr) 65 (0–93; 45, 76) 66 (0–91; 48, 77) 0.70
Male 639 (56.6) 255 (57.2) 0.85
Disease severity
Rapidly fatal 253 (22.4) 159 (35.7) < 0.0001
Ultimately fatal 517 (45.8) 170 (38.1) 0.005
Non-fatal 358 (31.8) 117 (26.2) 0.03
Hospitalization days before NI 19 (3–835; 11, 35) 26 (3–862; 15, 39) < 0.0001
Total hospital stay (d) 50 (3–1277; 29, 85) 37 (3–865; 25, 68) < 0.0001
Underlying medical illness
Malignancy 283 (25.1) 169 (37.9) < 0.0001
Solid tumors 219 (19.4) 127 (28.5) < 0.0001
Leukemia and lymphoma 64 (5.7) 42 (9.4) 0.008
Received C/T or R/T 177 (15.7) 113 (25.3) < 0.0001
Neurologic diseases 179 (15.9) 39 (8.7) 0.0002
Chronic renal diseases 114 (10.1) 66 (14.8) 0.008
Chronic heart disease 102 (9.0) 89 (20.0) < 0.0001
Congestive heart failure 29 (2.6) 37 (8.3) < 0.0001
Chronic liver disease 89 (7.9) 63 (14.1) 0.0002
Liver cirrhosis 49 (4.3) 55 (12.3) < 0.0001
Chronic lung disease 85 (7.5) 79 (17.7) < 0.0001
Recent operation 211 (18.7) 85 (19.1) 0.87
*Data are presented as median (range; 25th, 75th percentile) or n (%); †host characteristics such as acquired immunodeficiency syn-
drome, alcoholism, autoimmune diseases, diabetes, endocrine and metabolic diseases, gastrointestinal diseases, hematologic diseases
other than malignancies, musculosketetal diseases, premature birth, and urologic diseases were non-significant factors for mortality in
univariate analysis (p > 0.1). NI = nosocomial infection; C/T = chemotherapy; R/T = radiotherapy.
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p=0.002), more prolonged hospitalization before
NI onset (OR, 1.004 per day of hospital stay; p =
0.004), use of hemodialysis (OR, 5.15; p=0.0003),
arterial-line insertion (OR, 2.51; p < 0.0001), uri-
nary catheterization (OR, 2.36; p<0.0001), central
venous catheterization (OR, 2.08; p = 0.001),
bloodstream infections (OR, 2.75; p < 0.0001), NI
due to Candida spp. (OR, 2.95; p< 0.0001), multi-
ple NI episodes (OR, 2.34; p< 0.0001), occurrence
of septic shock (OR, 4.25; p < 0.0001) and occur-
rence of DIC (OR, 2.53; p < 0.0001) (Table 5).
Discussion
NI is one of the leading causes of hospital deaths,
along with cardiovascular disease, cancers, and
community-acquired infections.16,17 Previous re-
ports show that the mortality rate attributed to NI
ranges widely from 6.8% to 47%,1–4,16,17 with this
variance reflecting the study population (e.g. pa-
tients hospitalized in ICUs) and sites of NI.
Presently, we found that NI directly caused death
in 28.3% of patients, with NI-attributable mor-
tality among those patients admitted to the ICU
being 30.1%. The high mortality was associated
with severe underlying diseases, medical and sur-
gical interventions, recurrent and acute blood-
stream of NI, NI caused by Candida, and NI-related
complications. Despite the health care strides in
improvements in critical care and development
of multiple potent broad-spectrum antibiotics in
the past several decades, NI remains one of the
most important causes of in-hospital deaths.
Table 2. Univariate analysis of hospital factors (admission service and hospital interventions) before
occurrence of nosocomial infections (NI) in 1574 patients with NI*
Characteristics Survived (n = 1128) Died (n = 446) p
Services of NI onset
General medicine 559 (49.6) 169 (37.9) < 0.0001
Intensive care unit 303 (26.9) 177 (39.7) < 0.0001
Surgery 61 (5.4) 33 (7.4) 0.13
Oncology 86 (7.6) 54 (12.1) 0.005
Pediatrics 39 (3.4) 11 (2.5) 0.31
Orthopedics 37 (3.3) 2 (0.4) 0.001
Others† 43 (3.8) 0 (0) < 0.0001
Interventions before NI
Arterial catheterization 345 (31.3) 233 (52.2) < 0.0001
Chest tube insertion 27 (2.4) 23 (5.2) 0.005
Central venous catheterization 602 (53.4) 384 (86.1) < 0.0001
Hemodialysis 42 (3.7) 46 (10.3) < 0.0001
Mechanical ventilation 186 (16.5) 90 (20.2) 0.08
Urinary catheterization 516 (45.7) 366 (82.1) < 0.0001
Peripheral intravascular catheterization 945 (83.8) 387 (86.8) 0.14
Port-A device 192 (17.0) 104 (23.3) 0.004
External hepatobiliary drainage 27 (2.4) 16 (3.6) 0.19
Swan-Ganz catheterization 58 (5.1) 51 (11.4) < 0.0001
Endoscopic examination 46 (4.1) 60 (13.4) < 0.0001
Surgical wound (gastrostomy, 48 (4.3) 12 (2.7) 0.15
colostomy, open wound)
Total parenteral nutrition 50 (4.4) 39 (8.7) 0.0008
Use of steroid or immune suppressants 52 (4.6) 83 (18.6) < 0.0001
*Data are presented as n (%); †including services of rehabilitation (n = 16), ear-nose-throat (8), obstetrics-gynecology (6), urology (5),
neurology (5), dentistry (1), dermatology (1), psychiatry (1).
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Table 3. Univariate analysis of microbial factors (sites and causative pathogens) of nosocomial 
infections (NI) in 1574 patients with NI*
Characteristics Survived (n = 1128) Died (n = 446) p
Sites of NI
Bloodstream 526 (46.6) 253 (56.7) 0.0003
Urinary tract 365 (32.3) 109 (24.4) 0.002
Surgical wound 96 (8.5) 25 (5.6) 0.05
Bone and joint 49 (4.3) 18 (4.0) 0.79
Respiratory tract 46 (4.1) 20 (4.5) 0.72
Skin 13 (1.2) 7 (1.6) 0.51
Others 33 (3.0) 14 (3.2) 0.82
Pathogens of NI
Gram-positive bacteria 222 (19.7) 124 (27.8) 0.0004
Staphylococcus aureus 113 (10.0) 66 (14.8) 0.007
Enterococcus species 40 (3.5) 23 (5.2) 0.14
Streptococcus species 36 (3.2) 21 (4.7) 0.15
Co-NS 20 (1.8) 9 (2.0) 0.74
Others 13 (1.1) 5 (1.1) 0.95
Gram-negative bacteria 667 (59.1) 206 (46.2) < 0.0001
Pseudomonas aeruginosa 130 (11.5) 29 (6.5) 0.003
Escherichia coli 121 (10.7) 29 (6.5) 0.01
Enterobacter species 109 (9.7) 36 (8.1) 0.33
Klebsiella species 107 (9.5) 33 (7.4) 0.19
Acinetobacter baumannii 102 (9.0) 32 (7.2) 0.23
Stenotrophomonas maltophilia 11 (0.9) 18 (4.0) < 0.0001
Serratia marcescense 10 (0.9) 10 (2.2) 0.03
Others 77 (6.8) 19 (4.2) 0.06
Candida species 148 (13.1) 107 (24.0) < 0.0001
Molds 2 (0.2) 3 (0.7) 0.12
Anaerobes 11 (9.8) 8 (1.8) 0.18
*Data are presented as n (%). Co-NS = coagulase-negative Staphylococci.
Table 4. Univariate analysis of complication factors (treatment and complications) in 1574 patients with
nosocomial infections (NI)*
Survived (n = 1128) Died (n = 446) p
Treatment
Initial appropriate antibiotic use 838 (74.3) 335 (75.1) 0.74
Multiple drug (≥ 3 classes) resistance 585 (51.9) 237 (53.1) 0.65
Multiple (≥ 3 classes) combination of antibiotics 482 (42.7) 199 (44.6) 0.49
Multiple (≥ 2) episodes of NI 382 (33.9) 210 (47.1) < 0.0001
Complications
Disseminated intravascular coagulation 116 (10.3) 158 (35.4) < 0.0001
Gastrointestinal bleeding 75 (6.6) 46 (10.3) 0.01
Acute renal failure 31 (2.7) 34 (7.6) < 0.0001
Cardiopulmonary resuscitation 23 (2.0) 25 (5.6) 0.0002
Septic shock 15 (1.3) 54 (12.1) < 0.0001
Acute respiratory distress syndrome 5 (0.4) 10 (2.2) 0.0009
*Data are presented as n (%).
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We found that the mortality rate attributable
to NI varied according to different patient popu-
lations and types of medical care. ICU hospital-
ization has been identified as an independent
risk factor for NI-associated deaths in several
studies.17–19 Patients admitted to the ICU have
some severe acute events, which would further
compromise their clinical condition. Further-
more, the more prevalent immunocompromised
condition of ICU patients and relatively higher
exposure rates of ICU patients to invasive proce-
dures also represent independent risk factors for
NI-associated deaths. Presently, more than two-
thirds of deaths were within 2 weeks of NI onset
and most occurred in the first 5 days. However,
deaths due to NI could also develop after 35 days
after NI [this study]. Thus, study by using 30-day
in-hospital mortality may not be an adequate
predictor of NI-associated mortality.
Detailed physiologic assessment scores (e.g.
APACHE II scores) illuminate a strong relation-
ship between the severity of illness and subse-
quent probability of death.18 However, for reasons
of interventional expediency and/or economics,
not every hospitalized patient may have the requi-
site detailed blood biochemistry and arterial blood
gas analyses. Our study shows that McCabe dis-
ease severity classification correlates well with 
in-hospital fatality due to NI, supporting its use
as a more convenient and easy-to-predict out-
come for NI. Similar to other studies,17,18 current 
observations do not support age alone as being a
determining factor for mortality.
Our study confirmed that prolonged hospital-
ization and repeated episodes of NI are associated
with NI-related deaths.3,19,20 We also confirmed
that bloodstream infection and NI due to Candida
are most ominous for patient outcome,4,19,21 and
Table 5. Independent risk factors associated with nosocomial infection (NI)-associated mortality, 
assessed by multiple logistic regression analysis
Variables p OR 95% CI
Host factors
Disease severity* < 0.0001 8.21 4.67–15.38
Liver cirrhosis < 0.0001 5.58 2.62–11.89
Solid tumor < 0.0001 2.56 1.61–4.07
Chronic lung disease 0.003 1.99 1.27–3.12
Congestive heart failure 0.005 1.75 1.01–3.07
Hospital service
Intensive care unit 0.002 1.61 1.57–4.29
Hospital stay before NI† 0.004 1.004 1.00–1.01
Hospital intervention
Hemodialysis 0.0003 5.15 2.81–13.81
Arterial line insertion < 0.0001 2.51 1.75–3.52
Urinary catheterization < 0.0001 2.36 1.67–3.32
Central venous catheterization 0.001 2.08 1.18–3.66
Sites and pathogens of NI
Bloodstream infection < 0.0001 2.75 1.88–7.04
Fungal infection < 0.0001 2.95 1.76–4.92
Multiple episodes of NI < 0.0001 2.34 1.44–2.32
Complications of NI
Shock < 0.0001 4.25 2.24–8.13
DIC < 0.0001 2.53 1.85–3.46
*Disease severity was analyzed as rapidly fatal diseases vs. non-fatal diseases; †odds ratio was 1.004 as increment of per day of hospital
stay before onset of NI. OR = odds ratio; CI = confidence interval; DIC = disseminated intravascular coagulation.
that many medical or surgical interventions (such
as insertion of catheters and dialysis) are inde-
pendent risk factors for mortality. The latter indi-
cates that the aseptic technique and care of catheter
wound should be more prominently conveyed to
the health care community. A targeted educational
campaign highlighting specific problems in the
aseptic procedure and care of surgical and medical
interventions could help reduce the rate of NI, and
also reduce mortality. Our results indicate that the
adoption of national guidelines for NI prevention
is very important and emphasize the need for con-
trol activities associated with the use of indwelling
devices, including central venous catheters, arterial
catheters, and urinary catheters.
Although antibiotic resistance clearly limits
therapeutic options for treating NI, it is unclear
as to whether or not microbial resistance is asso-
ciated with increased mortality.5,22,23 Our results
do not support the view that NI caused by drug-
resistant bacteria increases the risk of death. This
lack of effect on mortality could be due to intrin-
sically low virulence of resistant bacteria or be-
cause of the presence of more outcome-defining
comorbid conditions in patients who develop in-
fections with the resistant organisms. Our results
also noted that early introduction of a combina-
tion of multiple antibiotics did not lower the risk
of death. The tendency to use broad-spectrum and
multiple antibiotics in immunocompromised pa-
tients with severe NI, who are also the susceptible
hosts of multiple-drug resistant bacterial infec-
tions, could mutually affect their impact on NI-
associated deaths.
In conclusion, the crude and attributable mor-
tality of NI remains high in modern medicine.
Despite decades of medical progress, the risk fac-
tors for mortality attributable to NI (such as dis-
ease severity and underlying host immune status)
have not changed appreciably. Because most fac-
tors associated with NI-attributable deaths cannot
be modified once NI has occurred, measures to
prevent NI, such as improving host immunity,
aseptic technique and good personal hygiene of
medical staff, should be the highest priority and
are more likely to reduce mortality due to the
devastating infection than seeking advances in sup-
portive care or antimicrobial therapy for patients
who are already infected.
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